US-localized diffuse optical tomography in breast cancer: Comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers

To correlate parameters of Ultrasonography-guided Diffuse optical tomography (US-DOT) with pharmacokinetic features of Dynamic contrast-enhanced (DCE)-MRI and pathologic markers of breast cancer.